investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Pathogenic Mechanisms of CSF3R Mutations in Leukemia
Julia E Maxson
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Julia E Maxson
Fred Hutchinson Cancer Research Center
Seattle, United States
Related projects
Danilo Perrotti
Role of microRNAs in the Regulation of CML Stem Cell Self Renewal and Survival
Leukaemia
Pathology
Peter Aplan
Collaborative Pathways that Lead to Leukemia
Leukaemia
Pathology
H Leighton Grimes
Developing Novel STAT5 Protein Inhibitors for Treatment of Leukemias
Leukaemia
Pathology
Bruce R Blazar
Cytotoxic-T-Lymphocyte (CTL) Therapy of Acute Myeloid Leukemia (AML)
Leukaemia
Pathology
Dong-Er Zhang
Molecular Mechanism of Leukemogenesis Involving AML1-ETO
Leukaemia
Pathology
George Calin
Deciphering the Role of Non-coding RNA in Chronic Lymphocytic Leukemia
Leukaemia
Pathology
Scott H Kaufmann
Regulation of Death Ligand-Induced Killing
Leukaemia
Pathology
Carol Prives
Properties and Regulation of p53 in Tumor Cells
Leukaemia
Pathology
Bruno Calabretta
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
Leukaemia
Pathology
